Zobrazeno 1 - 10
of 12
pro vyhledávání: '"59"'
Autor:
Baris Turkbey, Peter A. Pinto, Joanna H. Shih, Maria Merino, Peter L. Choyke, Ravi A. Madan, John R. Bright, Stephanie Harmon, Guinevere Chun, Fatima Karzai, Huihui Ye, Amy Hankin, Scott Wilkinson, Anna Couvillon, Marijo Bilusic, Lisa M. Cordes, Nicolas T. Terrigino, David J. VanderWeele, Rosina T. Lis, William L. Dahut, Nicole V. Carrabba, Stephanie M. Walker, Monique N. Williams, James L. Gulley, Adam G. Sowalsky
Publikováno v:
Clin Cancer Res
Purpose: For high-risk prostate cancer, standard treatment options include radical prostatectomy (RP) or radiotherapy plus androgen deprivation therapy (ADT). Despite definitive therapy, many patients will have disease recurrence. Imaging has the pot
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background: U.S. breast cancer incidence has been changing, as have distributions of risk factors, including body mass index (BMI), age at menarche, age at first live birth, and number of live births. Methods: Using data for U.S. women from large nat
Autor:
M Melé, Serafin Morales, Noelia Martínez, Jordi Canes, Begoña Bermejo, I Garau, Paolo Nuciforo, Patricia Villagrasa, Maria Jose Echarri, Antonia Perelló, Barbara Adamo, Blanca Gonzalez-Farre, Silvia Vazquez, Tomás Pascual, Xavier Gonzalez, Santiago Escrivá-de-Romaní, Patricia Galván, Sonia Pernas, Eva Ciruelos, Mafalda Oliveira, D. Martinez, Javier Cortes, Laia Paré, Alvaro Montaño, Aleix Prat, Eduardo Martínez, Estela Vega, Luis Manso
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
CLINICAL CANCER RESEARCH
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
CLINICAL CANCER RESEARCH
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
Purpose:To assess palbociclib in combination with trastuzumab with or without endocrine therapy in patients with HER2-positive advanced breast cancer.Patients and Methods:PATRICIA is a prospective, open-label, multicenter phase II trial. Patients had
Autor:
Jason J. Luke, Gary K. Schwartz, David Hogg, Bruno R. Bastos, Carrie Strand, Daniel J Olson, Timothy Carll, Yuanyuan Zha, Pamela N. Munster, Marcus O. Butler, Jacob B. Allred, Riyue Bao, Brian W. Labadie
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 26, iss 4
Clin Cancer Res
Clin Cancer Res
Purpose: The surface receptor MET is highly expressed on primary uveal melanoma; MET inhibitors demonstrated early clinical signals of efficacy in slowing uveal melanoma growth. The primary objective of our study was to compare the progression-free s
Autor:
Jirong Long, Anna H. Wu, Min-Ho Shin, Tabitha A. Harrison, Kenneth Offit, Ulrike Peters, Yoon-Ok Ahn, Fränzel J.B. Van Duijnhoven, Jochen Hampe, Qiuyin Cai, Stephanie J. Weinstein, Annika Lindblom, Zhi Zhong Pan, Keum Ji Jung, Chizu Tanikawa, Wanqing Wen, Andrew T. Chan, Wei Hua Jia, Yu-Tang Gao, Isao Oze, Keitaro Matsuo, Zefang Ren, Sun-Seog Kweon, Paul D.P. Pharoah, Victor Moreno, Pavel Vodicka, Yong-Bing Xiang, Jeroen R. Huyghe, Aesun Shin, Dong Hyun Kim, Sun Ha Jee, Koichi Matsuda, Jae Hwan Oh, Andrea Gsur, Yi Xin Zeng, Yingchang Lu, Nan Wang, Jiajun Shi, Wei Zheng, Bethany Van Guelpen, Loic Le Marchand, Li Li, Honglan Li, Jeongseon Kim, Alicja Wolk, Xingyi Guo, Polly A. Newcomb, Yoichiro Kamatani, Li Hsu, Jing Gao, Xiao-Ou Shu, Bingshan Li
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Cancer Epidemiology Biomarkers & Prevention 29 (2020) 2
Dipòsit Digital de la UB
Universidad de Barcelona
Cancer Epidemiology Biomarkers & Prevention, 29(2), 477-486
Cancer Epidemiology Biomarkers & Prevention 29 (2020) 2
Dipòsit Digital de la UB
Universidad de Barcelona
Cancer Epidemiology Biomarkers & Prevention, 29(2), 477-486
Background: Risk variants identified so far for colorectal cancer explain only a small proportion of familial risk of this cancer, particularly in Asians. Methods: We performed a genome-wide association study (GWAS) of colorectal cancer in East Asian
Autor:
Elizabeth Lamping, Elisa Bertotti, James L. Gulley, Marijo Bilusic, Joseph Kim, Julius Strauss, Agnes S. Montgomery, Matthew R. Silver, Ravi A. Madan, Jeffrey Schlom, Sheri McMahon, Jennifer L. Marte, Renee N. Donahue, Caroline Jochems, Christopher R. Heery
Publikováno v:
Clinical Cancer Research. 25:99-109
Purpose: The NHS-IL12 immunocytokine is composed of two IL12 heterodimers fused to the NHS76 antibody. Preclinical studies have shown that this antibody targets IL12 to regions of tumor necrosis by binding histones on free DNA fragments in these area
Autor:
Sarrah S. Lahorewala, Naureen N. Mullani, Michael Garcia-Roig, Mark S. Soloway, Asif Talukder, Soum D. Lokeshwar, Zachary Klaassen, Travis Yates, Murugesan Manoharan, Vinata B. Lokeshwar, Martin J.P. Hennig, Bruce R. Kava
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 27:464-472
Background: Aberrantly expressed miRNAs promote renal cell carcinoma (RCC) growth and metastasis and are potentially useful biomarkers for metastatic disease. However, a consensus clinically significant miRNA signature has not been identified. To ide
Autor:
Gian Luca De Salvo, Roberta Bertorelle, Alberto Amadori, Adolfo Favaretto, Fiorella Calabrese, Francesco Ciccarese, Angela De Paoli, Antonio Santo, Massimo Moro, Giovanni Esposito, Francesco Oniga, Giorgia Nardo, Laura Bonanno, Marco Chilosi, Alessandro Del Conte, Stefano Indraccolo, Pierfranco Conte, Elisabetta Zulato, Gabriella Sozzi, Cinzia Candiotto
Publikováno v:
Clinical Cancer Research. 23:3316-3324
Purpose: LKB1 is a key sensor of metabolic stress, including hypoxia and glucose deprivation, two features of the tumor microenvironment exacerbated by antiangiogenic therapy. We investigated the role of LKB1 as a potential predictive marker of sensi
Autor:
Henry S. Friedman, Luis Sanchez-Perez, Elizabeth A. Reap, Pam Norberg, Smita K. Nair, Weihua Xie, Kristen A. Batich, Patrick Healy, Gordana Vlahovic, Robert J. Schmittling, Duane Mitchell, Darell D. Bigner, James E. Herndon, Gary E. Archer, John H. Sampson, Allan H. Friedman, Roger E. McLendon
Publikováno v:
Clinical Cancer Research. 23:1898-1909
Purpose: Patients with glioblastoma have less than 15-month median survival despite surgical resection, high-dose radiation, and chemotherapy with temozolomide. We previously demonstrated that targeting cytomegalovirus pp65 using dendritic cells (DC)
Autor:
Wendy Y. Chen, Carla M. Prado, Adrienne Castillo, Patrick T. Bradshaw, Erin Weltzien, Candyce H. Kroenke, Bette J. Caan, Elizabeth M. Cespedes Feliciano
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 26:44-50
Background: Achieving a healthy weight is recommended for all breast cancer survivors. Previous research on postdiagnosis weight change and mortality had conflicting results. Methods: We examined whether change in body weight in the 18 months followi